Loading...

Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin

The aim of this study is to investigate the efficacy of combining a histone deacetylase inhibitor (LBH589) and a breast cancer stem cells (BCSC)-targeting agent (salinomycin) as a novel combination therapy for triple-negative breast cancer (TNBC). We performed in vitro studies using the TNBC cell li...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Breast Cancer Res Treat
Main Authors: Kai, Masaya, Kanaya, Noriko, Wu, Shang V., Mendez, Carlos, Nguyen, Duc, Luu, Thehang, Chen, Shiuan
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587767/
https://ncbi.nlm.nih.gov/pubmed/25904215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3376-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!